On 21 April 2026, Beauty Farm Medical and Health Industry Inc. (Beauty Farm) executed an on-market buyback of 37,000 ordinary shares, according to its Next Day Disclosure Return filed with the Hong Kong Stock Exchange on 21 April 2026.

The shares were repurchased at prices ranging from HK$20.66 to HK$21.16, resulting in a volume-weighted average cost of HK$21.0043 and an aggregate consideration of approximately HK$0.78 million. All repurchased shares will be held as treasury shares.

Following the transaction, Beauty Farm’s treasury share balance increased to 1,557,000, while its outstanding issued share capital (excluding treasury shares) decreased marginally to 250,036,715 shares—representing a 0.0148% reduction from the previous day. The total number of issued shares (including treasury shares) remains unchanged at 251,593,715.

The buyback was conducted under the general mandate granted on 27 June 2025, which authorises the company to repurchase up to 23.58 million shares. Cumulative repurchases under this mandate now stand at 1,557,000 shares, equivalent to 0.66% of the company’s issued shares when the mandate was approved.

In line with Hong Kong listing rules, Beauty Farm is subject to a 30-day moratorium on new share issues or treasury share sales, ending on 21 May 2026.